search index hum-molgen


HIV DART 2000, Frontiers in Drug Development for Antiretroviral Therapies
Ritz-Carlton, San Juan Hotel , Isla Verde, Puerto Rico
December 17-21, 2000

Conference Program Highlights

Opening session will comprise a presentation by Dr Anthony Fauci,
NIAID, National Institutes of Health on Sunday, December 17, 2000 at 2:00 PM.

Scientific sessions commence at 8:00 AM on Monday, December 18, 2000.

The conference program includes sessions covering the following topics:
Drug Design and Discovery: Viral Targets
Chemistry and Pre-Clinical Development
Viral Resistance
Phenotypic and Genotypic Assays
Immunotherapy in HIV Infection
First-line and Salvage Therapy
Treatment Failure and Drug Interactions
HIV/Hepatitis and other Co-infections
Vaccines/Therapeutic Vaccines

Organized by:

Informed Horizons, LLC

Invited Speakers:

Edward Acosta, University of Alabama at Birmingham, USA
Rafi Ahmed,Emory University School of Medicine, USA
Brigitte Autran, Groupe Hospitalier Pitié-Salpetrière, France
Dani Bolognesi, Trimeris, USA
Martin Bryant, Novirio Pharmaceuticals, Inc, USA
C.K. Chu, University of Georgia, USA
Francois Clavel, Hopital Bichat-Claude Bernard, France
David Cooper, University of New South Wales, Australia
Lawrence Corey, University of Washington at Seattle, USA
Erik De Clercq, Katholieke Universiteit Leuven, Belgium
Douglas Dieterich, New York University School of Medicine, USA
Anthony Fauci, NIAID, National Institutes of Health, USA
Courtney Fletcher, University of Minnesota, USA
Arnold Fridland, USA
Klaus Frueh, RW Johnson Pharmaceutical Research Institute, USA
Phillip Furman, Triangle Pharmaceuticals, USA
José Gatell, Hospital Clinic, Spain
John Gerber, University of Colorado, USA
Martin Hirsch, Massachusetts General Hospital, USA
Richard Hoetelmans, Sloltervaart Hospital, The Netherlands
Eric Hunter, University of Alabama at Birmingham, USA
Jean-Louis Imbach, Universite Montpellier, France
Christine Katlama, Groupe Hospitalier Pitié-Salpetrière, France
Paolo La Colla, Università di Cagliari, Italy
Joep Lange, Academic Medical Centre, The Netherlands
Brendan Larder, VIRCO, UK
Franco Lori, Progetto Right Laboratori di Biotecnologie, Italy
John Mellors, University of Pittsburgh, USA
Tom Merigan, Stanford University, USA
Julio Montaner, BC Centre for Excellence in HIV Infection, Canada
Robert Murphy, Northwestern University, USA
Michael Otto, Pharmasset, Inc, USA
Christos Petropoulos, ViroLogic, Inc, USA
Richard Pollard, University of Texas Medical Branch, USA
Bruce Polsky, St Luke's-Roosevelt Hospital Center, USA
Douglas Richman, University of California San Diego/VAMC, USA
José Rodriguez, University of Puerto Rico, Puerto Rico
Maribel Rodriguez-Torres, Fundación Gastroenterologia De Diego, Puerto Rico
Walter Scott, University of Miami School of Medicine, USA
Julie Strizki, Schering-Plough Pharmaceuticals, USA
Stefano Vella, Istituto Superiore di Sanità, Italy
Mark Wainberg, McGill University AIDS Centre, Canada
Carlos Zala, Fundación Huésped, Argentina

Deadline for Abstracts:

November 6, 2000


Conference registration fee US $650
Accompanying guests US $230

Conference registration fee US $750
Accompanying guests US $260
Email for Requests and Registration:

Posted by: Margie Poole   Host:
date: September 13, 2000 21:06:35
Generated by meetings and positions 2.0 by Kai Garlipp
Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany.
4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.